Rothfuss Cristin sold SRPT
March 2, 2026 · Form 4 insider transaction
Rothfuss Cristin sold 408 shares of Sarepta Therapeutics, Inc. at $16.20 per share, a transaction worth $6.6K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
408
Price
$16.20
Total value
$6.6K
InsiderRothfuss Cristin
RoleOfficer
SecurityCommon Stock
Transaction codeF: Shares withheld for taxes
Transaction dateMarch 2, 2026
Filing dateMarch 3, 2026
Shares owned after139,348
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 1, 2024.